Edith Olah - Selected publications#

Selected from 137 publications (citations: 4050/3074; Hirsch-index: 37; cumulative impact factor: 407,594)

ALL PUBLICATIONS AVAILABLE: https://vm.mtmt.hu//search/slist.php?lang=0&AuthorID=1169389

1. Kovács ME, Papp J, Szentirmay Z, Otto Sz, OLAH E:
Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome
HUM MUTAT 30(2):197-203, 2009
IF: 6.887
Cit: 43

2. Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, Schackert HK, Steinke V, Holinski-Feder E, Morak M, Kloor M, Büttner R, Verwiel ET, van Krieken JH, Nagtegaal ID, Goossens M, van der Post RS, Niessen RC, Sijmons RH, Kluijt I, Hogervorst FB, Leter EM, Gille JJ, Aalfs CM, Redeker EJ, Hes FJ, Tops CM, van Nesselrooij BP, van Gijn ME, García EB, Eccles DM, Bunyan DJ, Syngal S, Stoffel EM, Culver JO, Palomares MR, Graham T, Velsher L, Papp J, OLAH E, Chan TL, Leung SY, van Kessel AG, Kiemeney LA, Hoogerbrugge N, Ligtenberg MJ:
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
LANCET ONCOLOGY 12(1):49-55, 2011 Jan (Epub 2010 Dec 8.)
IF: 17.764
Cit: 10

3. Papp J, Kovacs ME, Solyom S, Kasler M, Borresen-Dale AL, OLAH E:
High prevalence of germline STK11 mutations in Hungarian Peutz-Jeghers Syndrome patients
BMC MED GENET 11:169, 2010 (Epub 2010 Nov 30.)
IF: 2.439
Cit: 4

4. Orbán TI, OLAH E:
Emerging roles of BRCA1 alternative splicing (invited review)
J CLIN PATHOL: MOL PATHOL 56:191-197, 2003
IF: 1.263
Cit: 47

5. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, OLAH E, Anton-Culver H, Warner E, Lubinski J, Gronwald V, Gorski B, Tulinius H, Thorlacius S, Eerola Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF:
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history, a combined analysis of 22 studies
AM J HUM GENET 72(5):1117-1130, 2003
IF: 11.602
Cit: 809

6. Orbán TI, OLAH E:
Purifying selection on silent sites – a constraint from splicing regulation?
TRENDS GENET 17:252-253, 2001
IF: 12.417
Cit: 27

7. Csókay B, Udvarhelyi N, Sulyok Z, Besznyák I, Ramus S, Ponder B, OLAH E:
High frequency of germline BRCA2 mutations among Hungarian male breast cancer patients without family history
CANCER RES 59(5):995-998, 1999
IF: 8.614
Cit: 41

8. Ramus S, Járai-Köte Zs, Friedman V, van der Looij M, Gayther SA, Csókay B, Ponder BAJ, OLAH E:
Analysis of BRCA1 and BRCA2 mutations in Hungarian breast and/or ovarian cancer families
AM J HUM GENET 60:1242-1246, 1997
IF: 10.244
Cit: 45

9. Ramus S, Friedman LS, Gayther SA, Ponder BAJ, Bobrow LG, van der Looij M, Papp J, OLAH E:
A breast/ovarian cancer patient with germline mutations in both the BRCA1 and BRCA2
NAT GENET 15:14-15, 1997
IF: 38.854
Cit: 45

10. OLAH E, Natsumeda Y, Ikegami T, Köte Zs, Horányi M, Szelényi J, Paulik E, Kremmer T, Hollán SR, Sugár J, Weber G:
Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells
PROC NATL ACAD SCI USA 85:6533 6537, 1988
IF: 10.032
Cit: 137

Scientific metrics for above 10 publications:
Cumulative impact factor: 120.116
Citations: 1208